drugset / Trial / NCT02646085

Multiparametric Imaging in Multiple Myeloma

NCT02646085 ↗

Phase 1 Completed 10 enrolled Yingbing Wang
NaSingle-groupOpen-labelDiagnostic

Summary

Patients with Multiple Myeloma will undergo single timepoint Positron Emission Tomography imaging with intravenously injected C11 Methionine to detect viable lesions.

Timeline

Start
2016-07
Primary completion
2021-06-30
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject C11 Methionine Diagnostic / imaging agent 370 mbq Intravenous

Indications